EUVIMEDEUVIMED entdecken
Crossref

COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti

Genetics and Molecular Research · 2026 · 25 (1s)

DOI: 10.4238/e91xh631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, 2026. Verfasst von Mahvash Khan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Khan, M., Malik, M. O., Sajjad, S., Uzair, M., Shah, I., & Bhatti, M. I. (2026). COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Genetics and Molecular Research, 25(1s). https://doi.org/10.4238/e91xh631

Vancouver

Khan M, Malik MO, Sajjad S, Uzair M, Shah I, Bhatti MI. COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Genetics and Molecular Research. 2026;25(1s). doi:10.4238/e91xh631

BibTeX
@article{Khan2026,
  author = {Khan, Mahvash and Malik, Muhammad Omar and Sajjad, Sara and Uzair, Muhammad and Shah, Inayat and Bhatti, Muhammad Ismail},
  title = {COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER},
  journal = {Genetics and Molecular Research},
  year = {2026},
  volume = {25},
  number = {1s},
  doi = {10.4238/e91xh631}
}
Kostenlos starten →